IP Library Patent Application 17497806
Patent Application
App. No. 17/497,806

CLOSED-LOOP CONTROL BASED ON PREDICTED TRAJECTORIES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/497,806
Abstract

Disclosed herein are techniques for closed-loop control based on predicted trajectories. The techniques may involve predicting a trajectory of a glucose level of a patient based on past observations of the glucose level. The techniques may further involve determining a cost expression based on the predicted trajectory. The cost expression may be based on a duration of time that the trajectory is predicted to extend outside of a target glucose concentration range. Additionally, the techniques may involve affecting, based on the cost expression, at least one future command to at least one infusion pump so as to shorten the duration of time that the trajectory is predicted to extend outside of the target glucose concentration range.

Claims (26)

1 . A processor-implemented method comprising:

predicting a trajectory of a glucose level of a patient based on past observations of the glucose level;

determining a cost expression based on the predicted trajectory, wherein the cost expression is based on a duration of time that the trajectory is predicted to extend outside of a target glucose concentration range;

affecting, based on the cost expression, at least one future command to at least one infusion pump so as to shorten the duration of time that the trajectory is predicted to extend outside of the target glucose concentration range.

2 . The method of claim 1 , wherein the at least one infusion pump comprises an insulin infusion pump.

3 . The method of claim 1 , wherein the at least one infusion pump comprises a glucagon infusion pump.

4 . The method of claim 1 , wherein the cost expression is defined to cover a set duration in the future.

5 . The method of claim 1 , wherein the predicting, the determining, and the affecting are performed on command intervals.

6 . A system comprising:

one or more processors; and

one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of:

predicting a trajectory of a glucose level of a patient based on past observations of the glucose level;

determining a cost expression based on the predicted trajectory, wherein the cost expression is based on a duration of time that the trajectory is predicted to extend outside of a target glucose concentration range;

affecting, based on the cost expression, at least one future command to at least one infusion pump so as to shorten the duration of time that the trajectory is predicted to extend outside of the target glucose concentration range.

7 . The system of claim 6 , wherein the at least one infusion pump comprises an insulin infusion pump.

8 . The system of claim 6 , wherein the at least one infusion pump comprises a glucagon infusion pump.

9 . The system of claim 6 , wherein the cost expression is defined to cover a set duration in the future.

10 . The system of claim 6 , wherein the predicting, the determining, and the affecting are performed on command intervals.

11 . One or more non-transitory processor-readable storage media storing instructions which, when executed by one or more processors, cause performance of:

predicting a trajectory of a glucose level of a patient based on past observations of the glucose level;

determining a cost expression based on the predicted trajectory, wherein the cost expression is based on a duration of time that the trajectory is predicted to extend outside of a target glucose concentration range;

affecting, based on the cost expression, at least one future command to at least one infusion pump so as to shorten the duration of time that the trajectory is predicted to extend outside of the target glucose concentration range.

12 . The one or more non-transitory processor-readable storage media of claim 11 , wherein the at least one infusion pump comprises an insulin infusion pump.

13 . The one or more non-transitory processor-readable storage media of claim 11 , wherein the at least one infusion pump comprises a glucagon infusion pump.

14 . The one or more non-transitory processor-readable storage media of claim 11 , wherein the cost expression is defined to cover a set duration in the future.

15 . The one or more non-transitory processor-readable storage media of claim 11 , wherein the predicting, the determining, and the affecting are performed on command intervals.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2021
From: ROY, ANIRBAN; KEENAN, DESMOND BARRY; KOVELMAN, PAUL H.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 058005/0232 →